E. |
Precautions |
Important: Please read the following precautions
carefully.
Follow precautions and instructions in this insert
to achieve the best results.
|
|
Safety |
*
|
This kit should only be used by properly trained personnel in an
appropriate laboratory environment. |
*
|
Treat PCDD/Fs, solutions that contain PCDD/Fs, and potentially
contaminated samples as hazardous materials. |
* |
Use gloves, proper protective clothing, and means to contain and handle
hazardous material where appropriate. |
* |
Obtain (if appropriate) permits pertaining to the handling, analysis and
transport of dioxin containing materials. |
* |
Stop solution is 1N hydrochloric acid. Handle carefully. |
|
Storage and General
Use of Kit |
* |
Do not freeze test kit components or expose them to temperatures
greater than 37°C (99°F). |
* |
If desiccant in tube bag is not blue, do not
use kit; contact CAPE
Technologies. |
* |
Do not expose substrate to direct sunlight. |
* |
Store all test kit components at 2°C to 6°C (36 °F to 43°F) when not
in use. |
* |
Storage at ambient temperature (20°C to 27°C or 68°F to 81°F) on the
day of use is acceptable. Do not store at ambient temperature for extended periods. |
* |
Allow all reagents to reach ambient temperature
(20°C to 27°C or 68°F to 81°F) before beginning the test.
This typically requires at least 60 minutes at ambient temperature
to warm from recommended storage conditions. Warming will
occur faster if bottles are removed from the kit box. |
* |
Do not use test kit components after the expiration date. |
* |
Do not use reagents or test tubes from one test kit
with reagents or test tubes from a different test kit. |
|
Sample Preparation
|
* |
Because this EIA recognizes many of the congeners in mass labeled
internal standard mixtures designed for GC-MS methods, EIA samples must contain either
immunoassay internal standards or no internal standards. Consult CAPE Technologies Technical Note TN-001 for specific recommendations
regarding mass labeled internal standards. |
* |
Sample extracts must be evaporated to dryness
before redissolving in methanol for the EIA. Residual
solvents or excessive oil may cause clouding or milkiness
upon addition to the sample diluent. If this occurs, the test
result will be invalid and the cause should be corrected before
repeating the analysis. |
|
EIA Protocol |
* |
When adding standards and samples to the
EIA tubes, the methanol solutions must
be dispensed directly into the liquid and not
above the liquid surface or onto the side of the tube. |
|
Interpretation of
Results |
* |
Consult the appropriate CAPE
Technologies Application
Note for proper interpretation of results. |
* |
Use approved methodologies to confirm any positive results and a portion
of the negative results. |
* |
Distribution of PCDD/Fs in samples may vary greatly. The analyst is
responsible for determining sampling frequency and distribution. |
* |
Proper quality assurance is the responsibility of the analyst and is
strongly encouraged. |
|